Univo pharmaceuticals is publicly traded and one of the biggest vertically integrated Medical Cannabis company in Israel.

The full control of the value chain, from cultivation to end consumer, enables us to meet the highest quality standard and supply market’s demand.

Our facilities include a farm (GACP, IMC-GAP), manufactory (IMC-GMP), trade house, distribution center (GDP) and a pharmacy.



Our Representatives

Golan Bitton

Founder & CEO, UNIVO Pharmaceuticals

Founder & CEO

UNIVO Pharmaceuticals

Univo improves health and quality of life

We create top-quality medical cannabis based solutions, by holding full control over the value chain (Farm, Factory, Trade House and Pharmacy) and by research and development of strains and innovative products.

R&D

1600 ft2 Research Facility, licensed by the Israeli Ministry of Health to conduct research and development of the next - generation medical cannabis products and genetics.

4 patents for broad medical indication granted in Israel.

Joint ventures with Israeli and International companies.

Research & Development hub for entrepreneurs exploring new innovations and technologies.

Cultivation

5 Acres Amit Farm located in south of Israel.

Innovative agricultural techniques are being implemented to yield high quality cannabis strains for specific indications.

Cultivation is accomplished under GAP standards.

Our unique genetics is selected according to pharmaceutical standards and meets the most stringent Israeli regulatory requirements for the required composition of cannabinoids.

Manufacturing

All operations are certified with the IMC-GMP standard to produce cannabis flowers and oil extracts, therefore assuring high quality of our products.

Distribution

IMC-GDP Certified The UNIVO in-house distribution center works closely with our partners and clients to assure highest satisfaction.

Our products are available in pharmacies nationwide.